Skip to content
Drug recall · FDA · Published March 26, 2024

Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,

Glenmark Pharmaceuticals recalls 120mg Diltiazem capsules with failed dissolution test. Do not use if expired or from specific lot. Contact for details.

🇺🇸 FDA recall #D-0430-2024DrugGlenmark ›
Take action

Contact the company & request your remedy

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Glenmark Pharmaceuticals is recalling 120mg Diltiazem Hydrochloride Extended-Release Capsules due to a dissolution test failure. This could affect medication effectiveness if the capsules don't release the drug properly over time. Read more at govinfonow.com/recall/32757-glenmark-diltiazem-capsules-recall-failed-dissolution-test-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32757-glenmark-diltiazem-capsules-recall-failed-dissolution-test-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0430-2024

Cite this page

“Glenmark Diltiazem Capsules Recall: Failed Dissolution Test Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32757-glenmark-diltiazem-capsules-recall-failed-dissolution-test-risk. Based on FDA recall #D-0430-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0430-2024%22&limit=1).

Why it’s dangerous

The capsules failed a dissolution test at 12 months, meaning they might not release the drug correctly over time. This could lead to inconsistent medication levels in the body, potentially affecting treatment effectiveness.

Who’s affected

People with prescriptions for this medication who received the recalled lot (17230304) from Glenmark. Those with specific medical conditions requiring precise dosing may be at higher risk.

How to tell if you have this one

Check for the lot number 17230304 on the bottle. The product is a 120mg Diltiazem capsule, 100-count bottle, manufactured in India with an expiration date of 12/31/2024.

  • Brand
    Glenmark
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Expiration Date

    Verify the expiration date on the bottle; do not use if expired.

  2. Contact Manufacturer

    Reach out to Glenmark Pharmaceuticals for specific recall details and instructions.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is for a specific lot number due to a dissolution test failure. The product may not release medication properly, so it's not recommended for use.

How do I know if I have the recalled product?

Check for the lot number 17230304 on the bottle. The product is a 120mg Diltiazem capsule, 100-count bottle, manufactured in India with an expiration date of 12/31/2024.

What should I do if I have the recalled product?

Contact Glenmark Pharmaceuticals for specific instructions on what to do with the product.

Take action

Contact Glenmark

We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.

Subject: Recall D-0430-2024 — Glenmark Glenmark

Hello,

I own a Glenmark that is covered by recall D-0430-2024 from Glenmark.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0430-2024 (March 26, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0430-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA